EPLAW PATENT BLOG

UK – Unwired Planet International v. Huawei Technologies (FRAND)

Posted: May 6th, 2015

Unwired Planet International Limited v Huawei Technologies Co. Limited, Samsung Electonics Co. Limited, Google Inc and others, UK, High Court (Patents Court), Birss J, 24 April 2015 Unwired Planet has sued Huawei, Samsung and Google in the UK Patent’s Court, alleging that the defendants have infringed five patents said by Unwired Planet to be essential to […]

READ MORE

UK – Everseal v Document Management Solutions

Posted: April 22nd, 2015

Everseal Stationery Products Ltd v Document Management Solutions Ltd and others, Intellectual Property Enterprise Court, 1 April 2015, [2015] EWHC 842 (IPEC), HHJ Hacon The Intellectual Property Enterprise Court (IPEC) has found a patent for a “mailer” (a business form, letter etc which, after completion, is folded and then sealed around the edges) to be […]

READ MORE

ES – Arne Forsgren v. SPTO / Protein D SPC

Posted: April 16th, 2015

Mr. Arne Forsgren v. Spanish Patents and Trademarks Office, High Court of Justice (Contentious-Administrative Chamber – 2nd Section) of Madrid, Spain, 9 July 2014, Docket No. 945/2012. The wave of resolutions from the European Court of Justice (ECJ) concerning SPCs and the related interpretation of the provisions from the Regulation (EC) No. 469/2009 (hereinafter, “the […]

READ MORE

BE – Saint-Gobain v. Knauf Insulation

Posted: April 13th, 2015

Saint-Gobain v. Knauf Insulation, Belgian Supreme Court, 12 March 2015 Patent – Scope of protection – Theory of equivalents – Amendment of the patent application – Interpretation of the granted claim – Impact of amendment on the scope of protection A judgment deciding that the patent is not infringed, taking into account that the patent […]

READ MORE

UK – Warner-Lambert v Actavis

Posted: April 7th, 2015

Warner-Lambert LLC v (1) Actavis Group PTC EHF, (2) Actavis UK Ltd, (3) Caduceus Pharma Ltd v National Health Service Commissioning Board (Respondent) v (1) Teva UK Ltd, (2) Generics (UK) Ltd, (3) Dr Reddy’s Laboratories (UK) Ltd, (4) Consilient Health Ltd, (5) Sandoz Ltd, (6) Department of Health (Interested parties), Patents Court, 2 March […]

READ MORE

ES – Lundbeck & Almirall v. Synthon et al. / Escitalopram / Appeal

Posted: March 27th, 2015

H.Lundbeck A/S, Lundbeck España, S.A. & Almirall, S.A. v. Synthon Hispania, S.L., Cantabria Pharma, S.L., Mylan Pharmaceuticals, S.L. et al., Court of Appeals (15th Section) of Barcelona, Spain, 22 October 2014, Docket No. 371/2013 TRIPS Agreement and patentability of pharmaceuticals in Spain: another turn of the screw. — — — In a Decision rendered on […]

READ MORE

NL – Syngenta v. Dutch Patent Office: Rectification (extension) of SPC term after grant

Posted: March 5th, 2015

Syngenta v. Dutch Patent Office, Council of State, 18 February 2015, case no. 201406096/1/A3, with thanks to Edmon Oude Elferink, Conny Delissen, Willem Hoorneman and Rogier de Vrey, CMS Derks Star Busmann, for sending in a translation of the decision in English as well as a head note The Dutch Council of State -the highest […]

READ MORE

NL – Gallus Druckmaschinen v. MPS Systems

Posted: March 4th, 2015

Gallus Druckmaschinen GmBh v. MPS Systems B.V., District Court The Hague, the Netherlands, 4 March 2015, Case No. HA ZA 14-530, with thanks to Willem Hoyng and Robin van Kleeff, Hoyng Monegier, for providing the judgment as well as a head note Gallus started accelerated patent proceedings against MPS on the basis of a patent […]

READ MORE

UK – Hospira v. Genentech

Posted: March 4th, 2015

Hospira (UK) Limited v Genentech, Inc., England and Wales Court of Appeal (Elias, Kitchin and Floyd), London, UK, 6 February 2015, Neutral Citation Number: [2015] EWCA Civ 57 In this judgment the Court of Appeal in England and Wales decided a case regarding Genentech’s patent EP (UK) 1 210 115 relating to a dosing regimen […]

READ MORE

CJEU – request for preliminary ruling Genentech v. Hoechst

Posted: February 20th, 2015

Request for a preliminary ruling from the Cour d’appel de Paris (France) lodged on 9 December 2014 — Genentech Inc. v Hoechst GmbH, formerly Hoechst AG, Sanofi-Aventis Deutschland GmbH, (Case C-567/14) Question referred: ‘Must the provisions of Article 81 of the Treaty (now Article 101 TFEU) be interpreted as precluding effect being given, where patents […]

READ MORE